Luc Henry is a Marie Curie postdoctoral fellow at the Swiss Federal Institute of Technology (EPFL) in Lausanne, Switzerland, and a visiting researcher at the University of Ulm, Germany. After earning BSc and MSc degrees in biological chemistry at the EPFL, he worked as a research assistant in the cell biology laboratory of Gisou van der Goot and then embarked on a long trip, cycling from Europe to China across the Middle East and Central Asia. He subsequently earned a DPhil degree in chemical biology from the University of Oxford, working in the laboratory of Christopher J. Schofield. While completing his degree in Oxford, he held a short term postdoctoral position in cancer immunology at the University of Lausanne, working on the role of bone marrow-derived cells in breast cancer development. His current interest is in developing a yeast-based screen for drug target deconvolution.


  • 2012–present
    Postdoctoral Fellow, Swiss Federal Institute of Technology in Lausanne
  • 2012–2012
    Postdoctoral Researcher, University of Lausanne


  • 2012 
    University of Oxford, DPhil
  • 2007 
    Swiss Federal Institute of Technology in Lausanne, MSc
  • 2005 
    Swiss Federal Institute of Technology in Lausanne, BSc


  • 2013
    The enzymes of β-lactam biosynthesis, Natural Product Reports
  • 2013
    TIE-2 and VEGFR kinase activities drive TIE-2-expressing monocytes immunosuppressive function in human breast tumors, Clinical Cancer Research
  • 2012
    γ-Butyrobetaine hydroxylase catalyses a Stevens type rearrangement, Bioorganic & medicinal chemistry letters
  • 2011
    Crotonase Catalysis Enables Flexible Production of Functionalized Prolines and Carbapenams, Journal of the American Chemical Society
  • 2010
    Structural and mechanistic studies on γ-butyrobetaine hydroxylase, Chemistry & Biology